Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2015-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The MEOPA is used to obtain an analgesia of the short-term painful acts. To the population of elderly patients, the therapeutic resources to control the passing pain require in their manipulation a certain caution and are not divested of side effects badly tolerated at this age. An alternative in the opioid presents all its interest. The MEOPA is here an alternative of choice in the care of these pains, in particular in case of pre-existent cognitive achievement, of polypathologies or of polymédication.

The gas MEOPA administered to the mask could thus be an effective additive in the physiotherapy treatment of the elderly person.

The main objective is to Assess the efficacy , in terms of recovery of the hip and knee joint articular amplitude, of 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Postoperative Patient-controlled Perineural Analgesia After Orthopedic Surgery by "Remote Control" Versus "Bedside Care"

NCT02018068

Injury of Foot, Shoulder or Knee Perineural Analgesia Pain, Postoperative

TERMINATED NA

Study Comparing a Nerve Block With Spinal Opiate to Provide Pain Relief for Hip Replacement Surgery

NCT01217294

Analgesia

COMPLETED NA

Compare Epidural vs. Lumbar Plexus Analgesia After Hip Arthroplasty

NCT02493621

Arthropathy of Hip

COMPLETED

Pain Control Following Total Hip Arthroplasty

NCT05062356

Chronic Postoperative Pain

COMPLETED PHASE1

Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement

NCT03744065

Hip Osteoarthritis Pain, Acute Pain, Postoperative +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Management and Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MEOPA

ENTONOX (MEOPA)gas Duration of treatment of a subject according to the protocol: 60 MINUTES Inhalation use

Group Type EXPERIMENTAL

MEOPA

Intervention Type DRUG

3 sessions of reeducation using MEOPA

Without MEOPA

Physiotherapit care without MEOPA

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MEOPA

3 sessions of reeducation using MEOPA

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female aged 65 years old or more
* Patients having a prescription for physiotherapy
* Absence of contraindication to MEOPA
* Patients whose initial assessment show a passive articular deficit of at least a joint of hip or the knee and whose painful assessment is ≥ 5 or ≥ 2 during mobilisation on the validated scale Algoplus
* Patients whose reeducation project established by the physiotherapist
* Patients having agreed to participate in the study and having signed the consent
* Subjects affiliated to the social security system

Exclusion Criteria

* Patient requiring a ventilation in pure oxygen
* Patient with a consciousness deterioration preventing his cooperation
* Care under MEOPA during the period of the protocol and during the month which precedes
* Increase of the dosage of morphine of less than 48 hours Patient under guardianship

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No